Literature DB >> 26709994

[The role of the nucleus accumbens in psychiatric disorders].

I Mavridis1.   

Abstract

The nucleus accumbens is the most inferior part of the striatum and is mainly connected to the limbic system. It is neurochemically and immunohistochemically divided into a shell laterally and a core medially. As a functionally central structure between amygdala, basal ganglia, mesolimbic dopaminergic regions, mediodorsal thalamus and prefrontal cortex, the nucleus accumbens appears to play a modulative role in the flow of the information from the amygdaloid complex to these regions. Dopamine is a major neurotransmitter of the nucleus accumbens and this nucleus has a modulative function to the amygdala-basal ganglia-prefrontal cortex circuit. Together with the prefrontal cortex and amygdala, nucleus accumbens consists a part of the cerebral circuit which regulates functions associated with effort. It is anatomically located in a unique way to serve emotional and behavioral components of feelings. It is considered as a neural interface between motivation and action, having a key-role in food intake, sexual behavior, reward-motivated behavior, stress-related behavior and substance-dependence. It is involved in several cognitive, emotional and psychomotor functions, altered in some psychopathology. Moreover it is involved in some of the commonest and most severe psychiatric disorders, such as depression, schizophrenia, obsessive-compulsive disorder and other anxiety disorders, as well as in addiction, including drugs abuse, alcoholism and smoking. Nucleus accumbens has also a role in other psychiatric disorders such as bipolar disorder, attention deficit/ hyperactivity disorder and post-traumatic stress disorder. Because of its rich dopaminergic projections, this nucleus has been subject of many studies in animals as well as in humans, connecting its malfunction with the disturbed reward process observed in depression. Neuromodulation interventions targeting the nucleus accumbens are nowadays applied in strictly selected patients suffering from treatment-resistant depression, obsessive-compulsive disorder, Tourette syndrome and addiction to drugs or alcohol. Specifically, bilateral and unilateral (right) deep brain stimulation of the nucleus accumbens has been applied in obsessive-compulsive patients resulting into significant improvement of their symptoms and their quality of life. Nucleus accumbens deep brain stimulation has been also associated with antidepressant and anxiolytic effect, as well as quality of life improvement in patients suffering from severe resistant depression. Finally, this minimally invasive stereotactic procedure has been proved beneficial for all phenotypic components of the Tourette syndrome, with remarkable reduction of the syndrome's motor manifestations, including tics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26709994

Source DB:  PubMed          Journal:  Psychiatriki        ISSN: 1105-2333


  8 in total

Review 1.  Roles, molecular mechanisms, and signaling pathways of TMEMs in neurological diseases.

Authors:  Qinghong Chen; Junlin Fang; Hui Shen; Liping Chen; Mengying Shi; Xianbao Huang; Zhiwei Miao; Yating Gong
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Experience-dependent associations between distinct subtypes of childhood trauma and brain function and architecture.

Authors:  Jia Li; Guiling Zhang; Jian Wang; Dong Liu; Changhua Wan; Jicheng Fang; Di Wu; Yiran Zhou; Tian Tian; Wenzhen Zhu
Journal:  Quant Imaging Med Surg       Date:  2022-02

3.  Inverse changes in L1 retrotransposons between blood and brain in major depressive disorder.

Authors:  Shu Liu; Tingfu Du; Zeyue Liu; Yan Shen; Jianbo Xiu; Qi Xu
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

4.  Effects of mango and mint pod-based e-cigarette aerosol inhalation on inflammatory states of the brain, lung, heart, and colon in mice.

Authors:  Alex Moshensky; Cameron S Brand; Hasan Alhaddad; John Shin; Jorge A Masso-Silva; Ira Advani; Deepti Gunge; Aditi Sharma; Sagar Mehta; Arya Jahan; Sedtavut Nilaad; Jarod Olay; Wanjun Gu; Tatum Simonson; Daniyah Almarghalani; Josephine Pham; Samantha Perera; Kenneth Park; Rita Al-Kolla; Hoyoung Moon; Soumita Das; Min Byun; Zahoor Shah; Youssef Sari; Joan Heller Brown; Laura E Crotty Alexander
Journal:  Elife       Date:  2022-04-12       Impact factor: 8.713

Review 5.  New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism.

Authors:  Carlye A Szarowicz; Kathy Steece-Collier; Margaret E Caulfield
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

Review 6.  Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review.

Authors:  Margaux Poireau; Thomas Milpied; Angéline Maillard; Christine Delmaire; Emmanuelle Volle; Frank Bellivier; Romain Icick; Julien Azuar; Cynthia Marie-Claire; Vanessa Bloch; Florence Vorspan
Journal:  Brain Sci       Date:  2022-07-30

7.  The nucleus accumbens and ventral pallidum exhibit greater dopaminergic innervation in humans compared to other primates.

Authors:  Kristen N Hirter; Elaine N Miller; Cheryl D Stimpson; Kimberley A Phillips; William D Hopkins; Patrick R Hof; Chet C Sherwood; C Owen Lovejoy; Mary Ann Raghanti
Journal:  Brain Struct Funct       Date:  2021-05-25       Impact factor: 3.270

Review 8.  The Relationship between Neurocircuitry Dysfunctions and Attention Deficit Hyperactivity Disorder: A Review.

Authors:  Yuncheng Zhu; Daoliang Yang; Weidong Ji; Tianming Huang; Lianxue Xue; Xixi Jiang; Liangliang Chen; Fang Wang
Journal:  Biomed Res Int       Date:  2016-09-01       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.